Pulmonary Function Testing Systems Market Size, Share, And Trends Analysis Report By Type (Complete PFT Systems, Portable PFT Systems), By Test Type(Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), By Component (Software, Hardware, Service), By Application(Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), Based On Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 515 | Number of pages: 195 | Published Date: Apr 2022

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Pulmonary Function Testing Systems Market Size, Share, And Trends Analysis Report By Type (Complete PFT Systems, Portable PFT Systems), By Test Type(Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), By Component (Software, Hardware, Service), By Application(Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), Based On Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Pulmonary Function Testing Systems Market is valued at USD 508.0 Million in 2021 and is expected to reach USD 776.1 Million by 2028 with a CAGR of 6.64% over the forecast period.

Increasing prevalence of respiratory diseases, growth in the elderly population and the rising prevalence of lung cancer are the major drivers propelling market growth.

Market Analysis of Pulmonary Function Testing Systems:-

Pulmonary function tests (PFTs) are noninvasive tests that show how well the lungs are working. Pulmonary function tests system consists of a series of tests to determine and measure the effectiveness of pulmonary inhalation and exhalation functions. It can diagnose certain types of lung diseases such as asthma, bronchitis and emphysema, as well as determine the cause of shortness of breath. In recent years, issues related to respiration are increased to a substantial level partly due to factors such as climate change, rising air pollution and increased consumption of cigarettes. PFT systems are used for measuring lung volume, capacity, and rate of flow and gas exchange. The information derived from the test is accurate and help in diagnosing certain lung disorders as well as determining treatment or therapeutics for them. Doctors and medical experts recommend regular pulmonary function testing (PFT) for people of all age groups as it helps to stay in control of a person’s health. Furthermore, PFT is necessary for patients with existing lung dysfunction or past history of lung diseases.

Global pulmonary function testing systems market report is segmented on the basis of type, test type, component, application, end-user and region & country level. Based on type, global pulmonary function testing systems market is classified into complete PFT systems and portable PFT systems. Based on test type, market is classified into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration test, and high altitude simulation testing. Based on components, global pulmonary function testing systems market is classified into software, hardware and service. Based on application, market is classified into chronic obstructive pulmonary disease, asthma, chronic shortness of breath, and restrictive lung disease. Based on end-user, global pulmonary function testing systems market is classified into hospital/clinical laboratories and diagnostics laboratories.

The regions covered in this pulmonary function testing systems market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of pulmonary function testing systems is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Pulmonary Function Testing Systems Companies-

Global pulmonary function testing systems market report covers prominent players like CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, and among others.

Pulmonary Function Testing Systems Market is valued at USD 508.0 Million in 2021

Pulmonary Function Testing Systems Market Segmentation:-

By Type:

  • Complete PFT Systems
  • Portable PFT Systems

By Test Type:

  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximal Voluntary Ventilation
  • Oxygen Titration Test
  • High Altitude Simulation Testing

By Component:

  • Software
  • Hardware
  • Service

By Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease

By End-User:

  • Hospital/Clinical Laboratories
  • Diagnostics Laboratories

Market Dynamics:-

Increasing incidences of lung cancer, as well as other chronic lung-related diseases, is the main factor driving the growth of the global pulmonary function testing systems market. According to the American Cancer Society, in the United States around 228,150 new cases of lung cancer occur in 2019. Additionally, around 142,670 deaths occur from lung cancer (76,650 in men and 66,020 in women). In addition, the growing demand for minimally invasive tests to design an appropriate method of treating lung disease is also supplementing the market growth. Furthermore, excessive consumption of tobacco in the form of cigarettes has also accelerated the prevalence of lung cancer. This has become the main driver of demand in the global market for pulmonary function testing systems. Moreover, the growth of the geriatric population has also played a key role in the rapid growth of the global market. However, reimbursement problems and a shortage of qualified professionals may restrain the growth of the market.

Regional Analysis:-

North America is expected to account for the largest share of the pulmonary function testing systems market during the forecast period. This is attributed to the rising technological advancements in diagnostics, coupled with the increasing prevalence of respiratory diseases and other pulmonary disorders.

The European market for pulmonary function testing systems is expected to be the second-largest during the forecast period owing to the increasing prevalence of lung diseases such as asthma, COPD, and the increasing demand for lung function tests in this region. According to European Respiratory Journal, in Europe, almost 10? billion people <45?years of age have asthma. The prevalence of asthma in the European Union (EU) is 8.2% in adults and 9.4% in children. Asia-Pacific is estimated to be the fastest-growing market due to the increasing demand for pulmonary function testing devices in private hospitals and clinics.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2028
Market Size in 2021: USD 508.0 Million
Base year considered 2020
Forecast Period CAGR %:

6.64%

Market Size Expected in 2028: USD 776.1 Million
Tables, Charts & Figures: 175
Pages 200
Pulmonary Function Testing Systems Companies CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, and among others.
Segments Covered By Type, By Test Type, By Component, By Application, By End-User
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Pulmonary Function Testing Systems Market Report–

  • Global Market report covers in-depth historical and forecast analysis.
  • Global Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Market report helps to identify opportunities in the market place.
  • Global Market report covers extensive analysis of emerging trends and competitive landscape.

On Pulmonary Function Testing Systems Market Report is also available for the below Regions and Country:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA


Frequently Asked Questions (FAQ) :
Pulmonary Function Testing Systems Market is expected to reach USD 776.1 Million by 2028 with CAGR of 6.64% over the forecast period.
Pulmonary Function Testing Systems Market is valued at USD 508.0 Million in 2021
North America is expected to account for the largest share of the pulmonary function testing systems market during the forecast period.
Increasing incidences of lung cancer, as well as other chronic lung-related diseases, is the main factor driving the growth of global pulmonary function testing systems market.
CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, and among others.



Interested in this report?

Pulmonary Function Testing Systems Market Size, Share, Growth, And Industry Trends By 2028

report cover

Pulmonary Function Testing Systems Market Size, Share, And Trends Analysis Report By Type (Complete PFT Systems, Portable PFT Systems), By Test Type(Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), By Component (Software, Hardware, Service), By Application(Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), Based On Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?